176 related articles for article (PubMed ID: 26587388)
1. An optimised method for the production of MERS-CoV spike expressing viral pseudotypes.
Grehan K; Ferrara F; Temperton N
MethodsX; 2015; 2():379-84. PubMed ID: 26587388
[TBL] [Abstract][Full Text] [Related]
2. An Optimized Method for the Production Using PEI, Titration and Neutralizationof SARS-CoV Spike Luciferase Pseudotypes.
Carnell G; Grehan K; Ferrara F; Molesti E; Temperton N
Bio Protoc; 2017 Aug; 7(16):e2514. PubMed ID: 34541175
[TBL] [Abstract][Full Text] [Related]
3. Production, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes.
Di Genova C; Sampson A; Scott S; Cantoni D; Mayora-Neto M; Bentley E; Mattiuzzo G; Wright E; Derveni M; Auld B; Ferrara BT; Harrison D; Said M; Selim A; Thompson E; Thompson C; Carnell G; Temperton N
Bio Protoc; 2021 Nov; 11(21):e4236. PubMed ID: 34859134
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.
Hyseni I; Molesti E; Benincasa L; Piu P; Casa E; Temperton NJ; Manenti A; Montomoli E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32927639
[TBL] [Abstract][Full Text] [Related]
5. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
6. Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera.
Almasaud A; Alharbi NK; Hashem AM
Methods Mol Biol; 2020; 2099():117-126. PubMed ID: 31883092
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Folegatti PM; Bittaye M; Flaxman A; Lopez FR; Bellamy D; Kupke A; Mair C; Makinson R; Sheridan J; Rohde C; Halwe S; Jeong Y; Park YS; Kim JO; Song M; Boyd A; Tran N; Silman D; Poulton I; Datoo M; Marshall J; Themistocleous Y; Lawrie A; Roberts R; Berrie E; Becker S; Lambe T; Hill A; Ewer K; Gilbert S
Lancet Infect Dis; 2020 Jul; 20(7):816-826. PubMed ID: 32325038
[TBL] [Abstract][Full Text] [Related]
8. Murine Leukemia Virus (MLV)-based Coronavirus Spike-pseudotyped Particle Production and Infection.
Millet JK; Whittaker GR
Bio Protoc; 2016 Dec; 6(23):. PubMed ID: 28018942
[TBL] [Abstract][Full Text] [Related]
9. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
10. Production of Recombinant Replication-defective Lentiviruses Bearing the SARS-CoV or SARS-CoV-2 Attachment Spike Glycoprotein and Their Application in Receptor Tropism and Neutralisation Assays.
Thakur N; Gallo G; Elreafey AME; Bailey D
Bio Protoc; 2021 Nov; 11(21):e4249. PubMed ID: 34859135
[TBL] [Abstract][Full Text] [Related]
11. The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes.
Ferrara F; Molesti E; Böttcher-Friebertshäuser E; Cattoli G; Corti D; Scott SD; Temperton NJ
J Mol Genet Med; 2012; 7():309-14. PubMed ID: 23577043
[TBL] [Abstract][Full Text] [Related]
12. Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis.
Ferrara F; Temperton N
Methods Protoc; 2018 Jan; 1(1):. PubMed ID: 31164554
[TBL] [Abstract][Full Text] [Related]
13. More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation.
Toon K; Bentley EM; Mattiuzzo G
Viruses; 2021 Jan; 13(2):. PubMed ID: 33572589
[TBL] [Abstract][Full Text] [Related]
14. Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein.
Fukuma A; Tani H; Taniguchi S; Shimojima M; Saijo M; Fukushi S
Arch Virol; 2015 Sep; 160(9):2293-300. PubMed ID: 26138557
[TBL] [Abstract][Full Text] [Related]
15. The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus.
Scott SD; Kinsley R; Temperton N; Daly JM
Pathogens; 2016 Dec; 5(4):. PubMed ID: 27983716
[TBL] [Abstract][Full Text] [Related]
16. The use of equine influenza pseudotypes for serological screening.
Scott S; Molesti E; Temperton N; Ferrara F; Böttcher-Friebertshäuser E; Daly J
J Mol Genet Med; 2012; 6():304-8. PubMed ID: 23515229
[TBL] [Abstract][Full Text] [Related]
17. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
Tandon R; Mitra D; Sharma P; McCandless MG; Stray SJ; Bates JT; Marshall GD
Sci Rep; 2020 Nov; 10(1):19076. PubMed ID: 33154514
[TBL] [Abstract][Full Text] [Related]
18. Application and comparison of lyophilisation protocols to enhance stable long-term storage of filovirus pseudotypes for use in antibody neutralisation tests.
Neto MM; Wright E; Temperton N; Soema P; Ten Have R; Ploemen I; Scott S
J Appl Microbiol; 2023 Feb; 134(2):. PubMed ID: 36724296
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
20. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
